| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.097 | 0.01 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.02 |